###### Strengths and limitations of this study

-   This assessment of usage patterns of epidural injections has been conducted to describe the characteristics of all types of epidural injections in managing chronic spinal pain in the fee-for-service (FFS) Medicare population in the USA from 2000 to 2014.

-   The strengths of this assessment include use of 100% FFS Medicare population including those above and below 65 years of age.

-   One of the limitations is that the study is restricted to only the Medicare population and patients with Medicare Advantage plans have not been included which constitute between 20% and 30% of the population.

-   Additionally, while these results can be generalised to a great extent, caution must be exercised since in other population groups the usage might be materially different.

Introduction {#s1}
============

The reports of neurological complications from epidural injections have taken centre stage in the USA[@R1] and in other parts of the world over the years.[@R8] Even though the basis for such alarm and subsequent regulatory atmosphere has been criticised,[@R4] the explosive increase of numerous modalities to manage spinal pain including epidural injections and the economic impact have provided ammunition for such an atmosphere.[@R9] Reports from the US Burden of Disease Collaborators[@R19] and from other parts of the world[@R20] [@R21] have shown spinal pain occupying three of the five top categories of disability. In addition, the prevalence of chronic impairing low back pain has increased in one report 162% from 1992 to 2006, increasing from 3.9% to 10.2%.[@R22] Further, multiple assessments also have shown the chronicity of spinal pain long after its onset.[@R23] [@R24] The evidence of increasing burden of disease and disability across the globe coupled with increasing numbers of treatments have created an unacceptable situation with economic, social and healthcare impact. Further complicating this circumstance is the widely debated issues of efficacy of these interventions.[@R24]

The statistics show that epidural injections, including percutaneous adhesiolysis procedures, are the most commonly performed procedures in managing spinal pain among interventional techniques, varying from 58.6% in 2000 to 45.2% in 2014 of all interventional techniques.[@R15] The usage of epidural procedures, excluding percutaneous adhesiolysis, showed an overall increase of 165% or 96% per 100 000 fee-for-service (FFS) Medicare beneficiaries with an annual increase of 7.2% or 4.9% from 2000 to 2014[@R15] showing a slight decrease compared to 2000 to 2013, from a rate of 105.6% to an annual increase of 5.7%. Interlaminar epidural injections have increased at a slower pace. Among the epidural injections, continuous epidural injections with catheterisation and neurolytic epidural procedures have not been used in managing chronic spinal pain. Manchikanti *et al*,[@R11] in assessing Medicare FFS population in the USA from 2000 to 2013, showed an increase of 119% for cervical and thoracic interlaminar epidural injections and 11% for lumbosacral interlaminar and caudal epidural injections per 100 000 Medicare population with an annual increase of 6.2% or 0.8%, respectively. Contrasting these milder increases, they determined an explosive increase of 577% for lumbosacral transforaminal epidural injections and an 84% increase of cervical and thoracic transforaminal epidural injections per 100 000 Medicare population with an annual increase of 15.8% and 4.8%, respectively, during the same period.[@R11] [@R12] [@R14] Thus, the use of epidural injections has risen dramatically, despite discordant opinions of their effectiveness and their association with rare, but catastrophic complications.[@R24]

This study is undertaken with an aim of assessing the usage patterns and patterns of use of epidural injections in Medicare FFS population in the USA with the analysis of data from 2000 to 2014.

Methods {#s2}
=======

Approval by the Institutional Review Board (IRB) was not sought for this assessment as all analysis encompassed public use files (PUF) or non-identifiable data, which is non-attributable and non-confidential, available through the Centers for Medicare and Medicaid Services (CMS) database.[@R45] The study was performed using Strengthening the Reporting of Observational studies in Epidemiology (STROBE) guidance.[@R46]

Study design {#s2a}
------------

The study was designed to assess usage patterns of epidural injections, excluding continuous epidurals and neurolytic procedures, which constitute a small proportion used for chronic management, in the FFS Medicare population in the USA from 2000 to 2014.

Setting {#s2b}
-------

National database of specialty usage data files from CMS, USA, FFS Medicare.[@R45]

Participants {#s2c}
------------

Participants included the FFS Medicare recipients from 2000 to 2014.

For analysis, the current procedure codes for epidural injections were used. The CPT codes used included epidural codes CPT 62310, 62311 and transforaminal epidural codes CPT 64479, 64480, 64483 and 64484. These codes were identified for years 2000 to 2014. Subsequently, usage data were assessed based on the place of service, either the facility which included ambulatory surgery centres and hospital outpatient departments (HOPDs), or a non-facility setting---the office. The data are calculated for overall services for each technique, and the rate of services for 100 000 Medicare beneficiaries, and also based on the specialty.

Variables {#s2d}
---------

Multiple characteristics are assessed in this evaluation of the Medicare population and increase in the Medicare population from 2000 to 2014, usage of epidural procedures in the cervical, thoracic, lumbar and sacral spine. Additional characteristics assessed included various specialty designations and the settings in which the procedures were performed.

The description of various specialties was as follows: multiple specialties representing interventional pain physicians including interventional pain management −09, pain medicine −72, anaesthesiology −05, physical medicine and rehabilitation −25, neurology −13, psychiatry −26 were described as interventional pain management. Surgical specialties included orthopaedic surgery −20, general surgery −17 and neurosurgery −14. Radiologic specialties included diagnostic radiology −30 and −94 interventional radiology. All other physicians were grouped into a separate group (general physicians), and all other non-physician providers were considered as other providers.

Data sources {#s2e}
------------

The data were obtained from the CMS physician supplier procedure summary master data from 2000 through 2014.[@R45] These data provide all FFS Medicare participants below the age of 65 and above the age of 65 receiving epidural procedures.

Measures {#s2f}
--------

Allowed services were calculated from services submitted minus services denied and services with zero payments.

Allowed services were assessed for each procedure, and rates were calculated based on Medicare beneficiaries for the corresponding year and are reported as procedures per 100 000 Medicare beneficiaries.

Bias {#s2g}
----

The study was conducted with the internal resources of the primary author\'s practice without any external funding, either from industry or elsewhere. The data were purchased from CMS by the American Society of Interventional Pain Physicians (ASIPP). CMS\'s 100% data set consists of usage by CPT code with modifier usage (as an additional procedure or bilateral procedure), specialty codes, place of service, Medicare carrier number, total services and charges submitted, allowed and denied, and amount paid.

Study size {#s2h}
----------

The study size is large with inclusion of all patients under Medicare FFS undergoing epidural procedures for spinal pain from 2000 to 2014.

Data compilation {#s2i}
----------------

The data were compiled using Microsoft Access 2003 and Microsoft Excel 2003 (Microsoft, Redmond, Washington, USA).

Results {#s3}
=======

Participants {#s3a}
------------

Participants included the FFS Medicare recipients from 2000 to 2014.

Descriptive data {#s3b}
----------------

[Table 1](#BMJOPEN2016013042TB1){ref-type="table"} illustrates the characteristics of Medicare beneficiaries as well as the epidural injections provided to them. Medicare beneficiaries increased 35% from 2000 to 2014 compared to an increase of 99% in the rate (per 100 000 Medicare beneficiaries) of epidural injections with an annual increase of 5% compared to a 2.2% annual increase in the number of Medicare beneficiaries which is 2.6 times the increase of the population rate.

###### 

Characteristics of Medicare beneficiaries and epidural procedures excluding percutaneous adhesiolysis, continuous epidurals and neurolytic epidurals.

                                      US population   Medicare beneficiaries   Epidural services\*                                                                                   
  ----------------------------------- --------------- ------------------------ --------------------- -------- ------ ---------------- -------------- ----------------- ------ ------ ------
  Y2000                               282 172         35 077                   12.4                  39 632   14.0   34 262 (86.5%)   5370 (13.5%)   839 474 (80%)     NA     2118   --
  Y2001                               285 040         35 332                   12.4                  40 045   14.0   34 478 (86.1%)   5567 (13.9%)   989 034 (78%)     17.8   2470   16.6
  Y2002                               288 369         35 605                   12.3                  40 503   14.0   34 698 (85.7%)   5805 (14.3%)   1 172 248 (74%)   18.5   2894   17.2
  Y2003                               290 211         35 952                   12.4                  41 126   14.2   35 050 (85.2%)   6078 (14.8%)   1 342 829 (71%)   14.6   3265   12.8
  Y2004                               292 892         36 302                   12.4                  41 729   14.2   35 328 (84.7%)   6402 (15.3%)   1 611 887 (65%)   20.0   3863   18.3
  Y2005                               295 561         36 752                   12.4                  42 496   14.4   35 777 (84.2%)   6723 (15.8%)   1 747 771 (65%)   8.4    4113   6.5
  Y2006                               299 395         37 264                   12.4                  43 339   14.5   36 317 (83.8%)   7022 (16.2%)   1 844 182 (63%)   5.5    4255   3.5
  Y2007                               301 290         37 942                   12.6                  44 263   14.7   36 966 (83.5%)   7297 (16.5%)   1 915 227 (62%)   3.9    4327   1.7
  Y2008                               304 056         38 870                   12.8                  45 412   14.9   37 896 (83.4%)   7516 (16.6%)   2 017 132 (61%)   5.3    4442   2.7
  Y2009                               307 006         39 570                   12.9                  45 801   14.9   38 177 (83.4%)   7624 (16.6%)   2 112 511 (59%)   4.7    4612   3.8
  Y2010                               308 746         40 268                   13.0                  46 914   15.2   38 991 (83.1%)   7923 (16.9%)   2 205 307 (57%)   4.4    4701   1.9
  Y2011                               311 583         41 370                   13.3                  48 300   15.5   40 000 (82.8%)   8300 (17.2%)   2 289 213 (58%)   3.8    4740   0.8
  Y2012                               313 874         43 144                   13.8                  50 300   16.0   41 900 (83.3%)   8500 (16.9%)   2 304 993 (58%)   0.7    4582   −3.3
  Y2013                               316 129         44 704                   14.1                  51 900   16.4   43 100 (83.0%)   8800 (17.0%)   2 259 887 (58%)   −2.0   4354   −5.0
  Y2014                               318 892         46 179                   14.5                  53 500   16.8   44 600 (83.4%)   8900 (16.5%)   2 255 668 (57%)   −0.2   4216   −3.2
  Per cent change from 2000 to 2014   13.0            31.7                     16.8                  35.0     19.8   30.2             65.7           168.7             --     99.0   
  Geometric average change %)         0.9             2.0                                            2.2             1.9              3.7            7.3               --     5.0    

\*Epidural services=62310---cervical/thoracic interlaminar epidural injections; 62311---lumbar/sacral interlaminar epidural injections; 64479---cervical/thoracic transforaminal epidural injections; 64480---cervical/thoracic transforaminal epidural injections add-on; 64483---lumbar/sacral transforaminal epidural injections; 64484---lumbar/sacral transforaminal epidural injections add-on.

Usage characteristics {#s3c}
---------------------

[Table 2](#BMJOPEN2016013042TB2){ref-type="table"} and [figure 1](#BMJOPEN2016013042F1){ref-type="fig"} illustrate the usage characteristics of epidural injections in the Medicare population from 2000 to 2014. Overall epidural injections increased 99% per 100 000 Medicare beneficiaries with an annual increase of 5%. However, lumbosacral interlaminar and caudal epidural injections (CPT 62311) decreased 2% per 100 000 Medicare beneficiaries with a 0.2% annual decrease compared to an increase of 104% per 100 000 beneficiaries and a 5.2% annual increase for cervical/thoracic interlaminar epidural injections (CPT 62310). In contrast, lumbosacral transforaminal epidural injections (CPT 64483 and 64484) increased 609% per 100 000 population with an annual increase of 15% and cervical/thoracic transforaminal epidural injections (CPT 64479 and 64480) increased 93% with an annual increase of 4.8%. Thus, all the decrease in usage of interlaminar epidural injections were compensated by increases of transforaminal epidural injections in the lumbar spine. In addition, cervical and thoracic transforaminal epidural injections have been decreasing from 2011 to 2013 but have shown an increase in 2014. Using the number of patient episodes providing the services, lumbar/sacral interlaminar or caudal epidural injections (CPT 62311) decreased at a rate of −2% from 2000 to 2014, whereas the rate of usage in 2014 was 815 858 services with 1525 per 100 000 Medicare FFS population with a decrease of 12.2% from the previous year and the decreases observed from 2006 through 2014. In addition, the number of patient episodes with transforaminal epidural injections (CPT 64483) were slightly less with 763 793 services with 1428 per 100 000 Medicare population, with an increase of 15% from 2000 to 2014, with decreases observed in 2 years with 4.0% decrease in 2012 and 5.1% in 2013 with an increase of 4.7% in 2014. In 2000, 1560 patients per 100 000 Medicare population received lumbar and caudal epidural injections, whereas 214 received lumbar transforaminal epidural injections. These numbers decreased for interlaminar epidural injections from 1560 to 1525, whereas lumbar transforaminal epidural injections increased from 214 to 1428 per 100 000 Medicare population.

###### 

Utilisations of epidural injections in the fee-for-service Medicare population from 2000 to 2014

                                         Cervical/thoracic interlaminar epidurals (CPT 62310)   Lumbar interlaminar and caudal epidurals (CPT 62311)   Cervical/thoracic transforaminal epidurals   Lumbar/sacral transforaminal epidurals                                                                                                  
  -------------------------------------- ------------------------------------------------------ ------------------------------------------------------ -------------------------------------------- ---------------------------------------- ------ ------- -------- -------- -------- ----- ------- --------- --------- ----------- ------ ------
  2000                                   75 741                                                 191                                                    --                                           618 362                                  1560   --      13 454   9434     22 888   58    --      85 006    37 477    122 483     309    --
  2001                                   84 385                                                 211                                                    10.3                                         702 713                                  1755   12.5    14 732   8537     23 269   58    0.6     125 534   53 133    178 667     446    44.4
  2002                                   99 117                                                 245                                                    16.1                                         786 919                                  1943   10.7    18 583   10 835   29 418   73    25.0    177 679   79 115    256 794     634    42.1
  2003                                   109 783                                                267                                                    9.1                                          838 858                                  2040   5.0     21 882   15 769   37 651   92    26.0    242 491   114 046   356 537     867    36.7
  2004                                   130 649                                                313                                                    17.3                                         878 174                                  2104   3.2     25 182   18 094   43 276   104   13.3    363 744   196 044   559 788     1341   54.7
  2005                                   141 652                                                333                                                    6.5                                          945 350                                  2225   5.7     27 844   20 525   48 369   114   9.8     395 508   216 892   612 400     1441   7.4
  2006                                   146 748                                                339                                                    1.6                                          946 961                                  2185   −1.8    29 822   23 073   52 895   122   7.2     452 125   245 453   697 578     1610   11.7
  2007                                   156 415                                                353                                                    4.4                                          926 029                                  2092   −4.3    29 938   22 266   52 204   118   −3.4    506 274   274 305   780 579     1764   9.6
  2008                                   165 636                                                365                                                    3.2                                          905 419                                  1994   −4.7    32 286   24 003   56 289   124   5.1     572 340   317 448   889 788     1959   11.1
  2009                                   175 503                                                383                                                    5.1                                          888 166                                  1939   −2.7    37 012   27 487   64 499   141   13.6    632 658   351 685   984 343     2149   9.7
  2010                                   184 750                                                394                                                    2.8                                          888 421                                  1894   −2.3    40 003   29 888   69 891   149   5.8     679 117   383 128   1 062 245   2264   5.4
  2011                                   200 134                                                414                                                    5.2                                          914 324                                  1893   0.0     38 970   26 628   65 598   136   −8.8    710 638   398 519   1 109 157   2296   1.4
  2012                                   213 390                                                424                                                    2.4                                          925 179                                  1839   −2.8    35 945   21 293   57 238   114   −16.2   718 437   390 749   1 109 186   2205   −4.0
  2013                                   217 393                                                419                                                    −1.3                                         901 468                                  1737   −5.6    34 699   20 409   55 108   106   −6.7    700 820   385 098   1 085 918   2092   −5.1
  2014                                   208 741                                                390                                                    −6.9                                         815 858                                  1525   −12.2   37 944   21 587   59 531   111   4.8     763 793   407 745   1 171 538   2190   4.7
  Per cent of change from 2000 to 2014                                                                                                                                                                                                                                                                                                      
   Change                                176                                                    104                                                    --                                           32                                       −2     --      182      129      160      93    --      799       988       856         609    --
  Geometric average annual change (%)                                                                                                                                                                                                                                                                                                       
  Geometric average                      7.5                                                    5.2                                                    --                                           2.0                                      −0.2   --      7.7      6.1      7.1      4.8   --      17.0      18.6      17.5        15.0   --

Rate---per 100 000 Medicare beneficiaries.

![Frequency of usage of epidural injections by procedures from 2000 to 2014, in Medicare recipients.](bmjopen2016013042f01){#BMJOPEN2016013042F1}

As shown in [figure 2](#BMJOPEN2016013042F2){ref-type="fig"}, the proportion of epidural injections of all interventional techniques performed reduced 57% to 45% from 2000 to 2014.

![Frequency of usage of epidural injections and all other interventional pain management procedures from 2000 to 2014, in Medicare recipients.](bmjopen2016013042f02){#BMJOPEN2016013042F2}

Specialty characteristics {#s3d}
-------------------------

[Online supplementary appendices 1 and 2](#SM1){ref-type="supplementary-material"} illustrate the usage of epidural injections by various specialties. In the group of interventional pain management, including anaesthesiology, interventional pain management, pain medicine, physical medicine and rehabilitation, neurology and psychiatry, the rate of increase was 113% per 100 000 Medicare beneficiaries with an overall increase of 99% from 2000 to 2014. However, among these groups, physical medicine and rehabilitation showed an overall increase of 672% and 472% per 100 000 Medicare beneficiaries. Radiology, consisting of interventional radiology and diagnostic radiology, also showed an increasing rate of 167% per 100 000 Medicare beneficiaries from 2000 to 2014. Surgical specialties, including neurosurgery, orthopaedic surgery and general surgery, showed an increase of 58% from 2000 to 2014.

10.1136/bmjopen-2016-013042.supp1

Site of service characteristics {#s3e}
-------------------------------

Epidural injections are provided in multiple settings including HOPDs, ambulatory surgical centres (ASCs) and in physician\'s offices (in-office). There has been a significant shift over the years in epidural injections based on the location of the procedure\'s performance. In 2002, HOPD services constituted 54.3%, with ASCs providing 19.9% of the service, and in-office providing 25.8%. By 2014, the HOPD share decreased to 29.4%, the ASC share increased to 27.7% and the in-office share dramatically increased to 42.9% as shown in [online supplementary appendices 3 and 4](http://dx.doi.org/10.1136/bmjopen-2016-013042).

Main results {#s3f}
------------

-   Epidural injections increased 99% per 100 000 Medicare beneficiaries with an annual increase of 5% in FFS Medicare beneficiaries from 2000 to 2014. Lumbar interlaminar and caudal epidural injections constituted 36.2% of all epidural injections, with an overall decrease of 2% and an annual decrease of 0.2% per 100 000 Medicare beneficiaries.

-   Lumbosacral transforaminal epidural injections increased 609% with an annual increase of 15% from 2000 to 2014 per 100 000 Medicare population. However, the ratio of lumbosacral transforaminal epidural injections increased from 14.6% of all epidural injection in 2000 to 51.9% in 2014, thus, exceeding interlaminar epidural injections.

-   Site-of-service usage patterns showed a decrease in HOPDs associated with a dramatic increase in in-office procedures.

Discussion {#s4}
==========

Usage of epidural injections for chronic spinal pain in the FFS Medicare population in the USA increased dramatically from 2000 to 2014. The increase for epidural injections has been shown to be 99% per 100 000 Medicare beneficiaries with an annual increase of 5%, compared to the increase of Medicare beneficiaries per 100 000 population of 35% with an annual increase of 2.2% during the same period. The increases were predominantly noted for lumbar transforaminal epidural injections with a 609% increase per 100 000 Medicare population from 2000 to 2014 with an annual increase of 15.0%. The increases were modest with 93% for cervical and thoracic transforaminal epidural injections and 104% for cervical and thoracic interlaminar epidural injections per 100 000 Medicare population. Usage of cervical/thoracic interlaminar epidural injections decreased by 6.9%, from 217 393 to 208 741, from 2013 to 2014 and for lumbar/sacral interlaminar epidural injections 9% from 901 468 to 815 858, whereas there was an 8% increase in cervical/thoracic transforaminal epidural injections from 55 108 to 59 531 and an 8% increase in lumbar/sacral transforaminal epidural injections from 1 085 918 to 1 171 538. Dramatic increases were noted for lumbosacral transforaminal epidural injections from a baseline rate of 309 in 2000 to 2190 in 2014 for per 100 000 Medicare population, an increase of 609% or an annual rate of 15%. In contrast, interlaminar epidural injections in the lumbar spine, which also include caudal epidural injections, have decreased 2% with an annual decrease of 0.2% from 1560 in 2000 per 100 000 Medicare population to 1525 in 2014. Consequently, only interlaminar epidural injections correlated with overall Medicare beneficiary growth, which has been shown to be 35% and growth of Medicare beneficiaries above age 65 years vs below 65 years with 30.2% vs 65.7%. There was also change in site of service usage patterns with a decrease in HOPD use and a dramatic increase in in-office services. ASC share increased from 19.9% in 2002 to 27.7% in 2014 and in-office services dramatically increased from 25.8% in 2002 to 42.9% in 2014 (see [online supplementary appendices 3 and 4](http://dx.doi.org/10.1136/bmjopen-2016-013042)), whereas HOPD share decreased from 54.3% to 29.4%.

As shown in [online supplementary appendices 2 and 3](http://dx.doi.org/10.1136/bmjopen-2016-013042), specialty characteristics showed that an overwhelming majority of the procedures (89.5%) were performed by pain management specialists, which essentially remained stable over the years. Surgery was a distant second specialty with 4.5% and radiology followed with 3.8% usage. Surgical specialties performed fewer procedures when compared to 2000, whereas radiologists performed more procedures. General physicians and other providers including Certified Registered Nurse Anesthetists, nurse practitioners and Physician Assistants also provided a lesser number of epidural injections than in 2000.

The results demonstrated in this evaluation were similar to other recently performed evaluations.[@R11] However, these results are noteworthy compared to some of the previous studies, which focused on different aspects rather than assessment of growth and usage.[@R47] Friedly *et al*[@R47] [@R48] and Abbott *et al*[@R49] indicate that injection therapies were provided with lack of evidence for managing chronic low back pain. Abbott *et al*[@R49] also included analysis of a publication from the Office of Inspector General in 2010[@R50] with multiple recommendations to curb the growth of lumbosacral transforaminal epidurals that showed a lack of significant effect or, at most, mild influence. Another paradoxical development is that transforaminal epidural injections have exceeded the total number of lumbar interlaminar and caudal epidural injections starting in 2009, which essentially reversed a long-standing trend of a high proportion of interlaminar and caudal epidural injections compared to transforaminal epidural injections, despite multiple reports of complications and resultant warnings.[@R1] [@R11]

Some of the limitations for our assessment include lack of inclusion of patients participating in Medicare Advantage Plans, which could lead to exclusion of ∼20--30% of the population. Further, there is also potential for coding errors and elimination of procedures which are not commonly used for spinal pain, such as continuous epidural injections and neurolytic procedures, may underestimate the number of procedures performed. However, the advantages of this study include that we have used the full Medicare data instead of an extrapolation and also all Medicare FFS population instead of using only those 65 years or older.

The increasing prevalence, disability, healthcare costs and human toll of spinal pain, the increasing usage of all modalities, specifically epidural injections---the subject of this assessment---continue to incite controversy and provide the basis of the claims that epidural injections are overused, leading to inappropriate use, abuse and fraud without evidence of efficacy, medical necessity and indications.[@R12] [@R24] [@R37] [@R38] The supporters of various modalities continue to profess cautious use with demonstration of effectiveness and cost utility, claim that spinal pain continues to increase, along with its understanding, which continues to evolve over the years.[@R24] [@R39] [@R40] [@R51] Thus, epidural injections in managing chronic spinal pain are justified with moderate evidence available in support of these injections in appropriately conducted randomised trials and systematic reviews.[@R12] [@R24] [@R37] [@R38] [@R51] However, others have provided contradictory evidence with lack of effectiveness demonstrated in high-profile assessments.[@R25] [@R26] [@R37] These reports have been extensively critiqued.[@R24] [@R27] [@R52] In addition to substantial differences between proponents and opponents with the majority of the government-sponsored studies in the USA showing lack of effectiveness of epidural injections in managing low back and lower extremity pain, Lewis *et al*[@R39] [@R40] in two separate manuscripts funded by the National Health Services (NHS) and health technology assessment programme have presented positive results for epidural injections. In a systematic review and economic model of the clinical and cost-effectiveness of management strategies for sciatica performed for the health technology assessment,[@R39] results were positive for demonstrating the effectiveness of epidural corticosteroid injections. They[@R40] also showed, in a systematic review and network meta-analysis of comparative clinical effectiveness of management strategies for sciatica with review of 122 relevant studies and 21 treatment strategies, statistically significant improvement with epidural injections. In addition, network meta-analysis[@R40] also showed superiority of epidural injections to traction, percutaneous discectomy and exercise therapy.

Overall, this assessment shows a continued increase of usage from 2000 to 2011, with subsequent decreasing patterns of usage of epidural injections. However, large-scale and seemingly inappropriate increases in usage are related to lumbar transforaminal epidural injections, whereas there was a net decrease of lumbar interlaminar and caudal epidural injections. Even though epidural injections have constituted smaller increases when compared to other modalities, with continued controversy and the increase of 609% in lumbosacral transforaminal epidural injections from 2000 to 2014, and associated major complications related to transforaminal epidural injections, caution must be exercised in performing these procedures, specifically transforaminal epidural injections. Thus, it is essential not only to develop appropriate evidence, but also to synthesise the evidence using up-to-date randomised controlled trials and proper methodology without confluence of bias. With such analysis of the data, there is no superiority for transforaminal epidural injections compared to interlaminar epidural injections in the lumbar or cervical spine.[@R24] [@R27] [@R29] [@R30] [@R32] [@R57] [@R58]

Conclusions {#s5}
===========

The use of epidural injections escalated from 2000 to 2011 with a small decline since then. However, dramatic increases were shown in usage patterns of lumbar transforaminal epidural injections despite rare complications, warnings and measures reducing the overall impact.
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